Your browser is no longer supported. Please, upgrade your browser.
Settings
BSTC BioSpecifics Technologies Corp. daily Stock Chart
BSTC [NASD]
BioSpecifics Technologies Corp.
Index- P/E27.64 EPS (ttm)1.64 Insider Own42.56% Shs Outstand7.27M Perf Week0.22%
Market Cap329.40M Forward P/E23.48 EPS next Y1.93 Insider Trans0.00% Shs Float5.24M Perf Month-12.95%
Income11.90M PEG1.26 EPS next Q0.42 Inst Own57.80% Short Float2.23% Perf Quarter-11.00%
Sales27.70M P/S11.89 EPS this Y18.10% Inst Trans-0.24% Short Ratio4.21 Perf Half Y-13.28%
Book/sh8.66 P/B5.23 EPS next Y11.56% ROA18.00% Target Price72.00 Perf Year21.83%
Cash/sh7.03 P/C6.45 EPS next 5Y22.00% ROE20.60% 52W Range35.79 - 58.79 Perf YTD-18.65%
Dividend- P/FCF24.95 EPS past 5Y10.50% ROI19.60% 52W High-22.93% Beta1.79
Dividend %- Quick Ratio23.00 Sales past 5Y18.20% Gross Margin- 52W Low26.60% ATR1.98
Employees5 Current Ratio23.00 Sales Q/Q4.80% Oper. Margin64.60% RSI (14)34.96 Volatility5.85% 3.99%
OptionableNo Debt/Eq0.00 EPS Q/Q1.70% Profit Margin43.10% Rel Volume0.71 Prev Close45.24
ShortableYes LT Debt/Eq0.00 EarningsAug 08 Payout0.00% Avg Volume27.71K Price45.31
Recom2.00 SMA20-5.70% SMA50-7.83% SMA200-11.88% Volume19,734 Change0.15%
Mar-08-16Initiated Rodman & Renshaw Buy $60
Jul-16-15Initiated MLV & Co Buy $76
Nov-11-14Reiterated MKM Partners Buy $38 → $46
Aug-12-14Reiterated MKM Partners Buy $28 → $38
Jan-09-14Reiterated MKM Partners Buy $24.50 → $28
Dec-09-13Reiterated MKM Partners Buy $23.50 → $24.50
Apr-05-12Initiated MKM Partners Buy $26.50
Mar-15-12Initiated Stifel Nicolaus Buy $29
Jun-15-09Initiated Hapoalim Outperform $40
Aug-15-17 10:14AM  New Strong Sell Stocks for August 15th Zacks
Aug-09-17 09:19PM  BioSpecifics posts 2Q profit Associated Press
04:01PM  BioSpecifics Technologies Corp. Reports Second Quarter 2017 Financial Results PR Newswire
Aug-03-17 10:04PM  Biospecifics Technologies Corp. Value Analysis (NASDAQ:BSTC) : August 4, 2017 Capital Cube
Jul-21-17 08:36AM  Biospecifics Technologies Corp. breached its 50 day moving average in a Bullish Manner : BSTC-US : July 21, 2017 Capital Cube
Jul-11-17 02:10PM  ETFs with exposure to Biospecifics Technologies Corp. : July 11, 2017 Capital Cube
Jul-10-17 08:50AM  Biospecifics Technologies Corp. breached its 50 day moving average in a Bullish Manner : BSTC-US : July 10, 2017 Capital Cube
Jun-19-17 03:02PM  ETFs with exposure to Biospecifics Technologies Corp. : June 19, 2017 Capital Cube
Jun-16-17 12:06PM  Biospecifics Technologies Corp. :BSTC-US: Earnings Analysis: Q1, 2017 By the Numbers : June 16, 2017 Capital Cube
Jun-02-17 04:05PM  BioSpecifics Technologies Corp. to Present at the Jefferies 2017 Healthcare Conference PR Newswire
May-24-17 12:12PM  Pharma Stock With Triple-Digit Growth Forming Blotchy Base Investor's Business Daily
May-18-17 08:37AM  Biospecifics Technologies Corp. breached its 50 day moving average in a Bearish Manner : BSTC-US : May 18, 2017 Capital Cube
May-10-17 05:32PM  BioSpecifics posts 1Q profit Associated Press
04:05PM  BioSpecifics Technologies Corp. Reports First Quarter 2017 Financial Results PR Newswire
Apr-21-17 03:24PM  Biospecifics Technologies Corp. Value Analysis (NASDAQ:BSTC) : April 21, 2017 Capital Cube
Apr-20-17 08:20AM  Biospecifics Technologies Corp. breached its 50 day moving average in a Bullish Manner : BSTC-US : April 20, 2017 Capital Cube
Apr-18-17 08:00AM  BioSpecifics Technologies Corp. Initiates Phase 1 Clinical Trial of XIAFLEX for Treatment of Uterine Fibroids PR Newswire
Apr-07-17 04:02PM  ETFs with exposure to Biospecifics Technologies Corp. : April 7, 2017 Capital Cube
10:16AM  Biospecifics Technologies Corp. breached its 50 day moving average in a Bearish Manner : BSTC-US : April 7, 2017 Capital Cube
Mar-29-17 04:30PM  BioSpecifics Technologies Corp. to Present at the 16th Annual Needham Healthcare Conference PR Newswire
Mar-24-17 08:15AM  Biospecifics Technologies Corp. breached its 50 day moving average in a Bearish Manner : BSTC-US : March 24, 2017 Capital Cube
08:15AM  Biospecifics Technologies Corp. breached its 50 day moving average in a Bearish Manner : BSTC-US : March 24, 2017
Mar-23-17 01:04PM  BIOSPECIFICS TECHNOLOGIES CORP Financials
Mar-20-17 12:00PM  Biospecifics Technologies Corp. :BSTC-US: Earnings Analysis: Q4, 2016 By the Numbers : March 20, 2017 Capital Cube
12:00PM  Biospecifics Technologies Corp. :BSTC-US: Earnings Analysis: Q4, 2016 By the Numbers : March 20, 2017
10:01AM  Biospecifics Technologies Corp. :BSTC-US: Earnings Analysis: 2016 By the Numbers : March 20, 2017
Mar-16-17 04:19PM  BIOSPECIFICS TECHNOLOGIES CORP Files SEC form 10-K, Annual Report
Mar-15-17 05:27PM  BIOSPECIFICS TECHNOLOGIES CORP Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statement
08:12AM  BioSpecifics posts 4Q profit Associated Press
08:00AM  BioSpecifics Technologies Corp. Reports Fourth Quarter and Full Year 2016 Financial Results PR Newswire
Mar-13-17 09:01AM  Biospecifics Technologies Corp. breached its 50 day moving average in a Bullish Manner : BSTC-US : March 13, 2017 Capital Cube
09:01AM  Biospecifics Technologies Corp. breached its 50 day moving average in a Bullish Manner : BSTC-US : March 13, 2017
Mar-12-17 02:40PM  Biotechs Among 5 Stocks Setting Up for Major Breakouts TheStreet.com
02:40PM  Biotechs Among 5 Stocks Setting Up for Major Breakouts
Mar-07-17 06:50PM  Top Biotech May 'Unveil' Breakthrough Treatment And Breakout Move
Mar-06-17 05:03PM  BIOSPECIFICS TECHNOLOGIES CORP Files SEC form 8-K, Regulation FD Disclosure, Financial Statements and Exhibits
Feb-15-17 06:07AM  BIOSPECIFICS TECHNOLOGIES CORP Files SEC form 8-K, Other Events
Jan-31-17 09:25AM  Biospecifics Technologies Corp. breached its 50 day moving average in a Bearish Manner : BSTC-US : January 31, 2017 Capital Cube
09:25AM  Biospecifics Technologies Corp. breached its 50 day moving average in a Bearish Manner : BSTC-US : January 31, 2017
Jan-24-17 04:30PM  BioSpecifics Technologies Corp. to Present at NobleCon13 - Noble Capital Markets' Thirteenth Annual Investor Conference PR Newswire
Jan-19-17 10:20AM  Biospecifics Technologies Corp. Value Analysis (NASDAQ:BSTC) : January 19, 2017 Capital Cube
10:20AM  Biospecifics Technologies Corp. Value Analysis (NASDAQ:BSTC) : January 19, 2017
Jan-18-17 09:41AM  Biospecifics Technologies Corp. breached its 50 day moving average in a Bearish Manner : BSTC-US : January 18, 2017
Jan-06-17 06:02AM  BIOSPECIFICS TECHNOLOGIES CORP Files SEC form 8-K, Regulation FD Disclosure, Financial Statements and Exhibits
Dec-15-16 08:46AM  Is BioSpecifics Technologies Corp. (BSTC) A Good Stock To Buy Right Now? at Insider Monkey
Dec-06-16 06:02AM  BIOSPECIFICS TECHNOLOGIES CORP Files SEC form 8-K, Regulation FD Disclosure, Financial Statements and Exhibits
Dec-02-16 11:55AM  ETFs with exposure to Biospecifics Technologies Corp. : December 2, 2016
Nov-22-16 11:13AM  Biospecifics Technologies Corp. :BSTC-US: Earnings Analysis: Q3, 2016 By the Numbers : November 22, 2016
Nov-21-16 06:02AM  BIOSPECIFICS TECHNOLOGIES CORP Files SEC form 8-K, Other Events, Financial Statements and Exhibits
Nov-18-16 11:34AM  Will BioSpecifics Technologies (BSTC) Continue to Surge Higher? +5.25%
Nov-17-16 04:05PM  BioSpecifics Technologies Corp. Announces Positive Data from Phase 2b Study of CCH in Patients with Cellulite PR Newswire
Nov-14-16 06:18AM  BIOSPECIFICS TECHNOLOGIES CORP Files SEC form 8-K, Regulation FD Disclosure, Financial Statements and Exhibits
Nov-09-16 05:08PM  BioSpecifics posts 3Q profit +6.98%
04:49PM  BIOSPECIFICS TECHNOLOGIES CORP Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statement
04:42PM  BIOSPECIFICS TECHNOLOGIES CORP Files SEC form 10-Q, Quarterly Report
04:05PM  BioSpecifics Technologies Corp. Reports Third Quarter 2016 Financial Results PR Newswire
12:32PM  ETFs with exposure to Biospecifics Technologies Corp. : November 9, 2016
07:07AM  Q3 2016 Biospecifics Technologies Corp Earnings Release - Before Market Open
Nov-08-16 08:00AM  BioSpecifics Technologies Corp. to Present at Stifel 2016 Healthcare Conference PR Newswire
07:52AM  Biospecifics Technologies Corp. breached its 50 day moving average in a Bullish Manner : BSTC-US : November 8, 2016
Nov-07-16 01:57PM  BIOSPECIFICS TECHNOLOGIES CORP Files SEC form 8-K, Entry into a Material Definitive Agreement
Nov-02-16 08:00AM  BioSpecifics Technologies Corp. to Report Third Quarter 2016 Financial Results on Wednesday, November 9, 2016 PR Newswire
Oct-24-16 01:35PM  Top 5 valuable Pharma stocks : October 24, 2016
Oct-20-16 09:35AM  ETFs with exposure to Biospecifics Technologies Corp. : October 20, 2016
Sep-27-16 10:01AM  PAREXEL International (PRXL) Set to Acquire ExecuPharm
Sep-21-16 08:15AM  BioSpecifics Technologies (BSTC) Catches Eye: Stock Up 5.2%
Sep-20-16 09:00AM  Can The Uptrend Continue for BioSpecifics Technologies (BSTC)? +5.21%
Sep-13-16 08:25AM  Foamix Pharmaceuticals (FOMX) Jumps: Stock Rises 15.7%
Sep-07-16 10:58AM  Karyopharm Reports Positive Multiple Myeloma Study Data
Sep-02-16 08:00AM  BioSpecifics Technologies Corp. to Present at Two Upcoming September Conferences PR Newswire
Sep-01-16 08:45AM  Dipexium Pharmaceuticals (DPRX) in Focus: Stock Gains 8.5%
Aug-30-16 08:25AM  What Makes Collegium Pharmaceutical (COLL) a Strong Sell?
Aug-29-16 09:30AM  The Zacks Analyst Blog Highlights: Mylan, Teva Pharmaceutical, Lannett Company, BioSpecifics Technologies and USANA Health Sciences
08:32AM  Weakness Seen in Jazz Pharmaceuticals (JAZZ) Estimates: Should You Stay Away?
Aug-23-16 11:29AM  ETFs with exposure to Biospecifics Technologies Corp. : August 23, 2016
Aug-22-16 08:36AM  New Strong Buy Stocks for August 22nd
Aug-18-16 08:45AM  Catalyst Pharmaceuticals (CPRX) Looks Good: Stock Up 6.3%
Aug-15-16 04:26PM  BIOSPECIFICS TECHNOLOGIES CORP Files SEC form 8-K, Regulation FD Disclosure, Financial Statements and Exhibits
Aug-12-16 12:49PM  Biospecifics Technologies Corp. :BSTC-US: Earnings Analysis: Q2, 2016 By the Numbers : August 12, 2016
Aug-10-16 06:03AM  BIOSPECIFICS TECHNOLOGIES CORP Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statement
Aug-09-16 06:11PM  BioSpecifics posts 2Q profit
04:33PM  BIOSPECIFICS TECHNOLOGIES CORP Files SEC form 10-Q, Quarterly Report
04:05PM  BioSpecifics Technologies Corp. Reports Second Quarter 2016 Financial Results PR Newswire
07:07AM  Q2 2016 Biospecifics Technologies Corp Earnings Release - Before Market Open
Aug-02-16 08:00AM  BioSpecifics Technologies Corp. to Report Second Quarter 2016 Financial Results on Tuesday, August 9, 2016 PR Newswire
Jul-01-16 10:58AM  BIOSPECIFICS TECHNOLOGIES CORP Files SEC form 8-K, Regulation FD Disclosure, Financial Statements and Exhibits
Jun-13-16 11:06AM  BIOSPECIFICS TECHNOLOGIES CORP Files SEC form 8-K, Other Events, Financial Statements and Exhibits +6.30%
08:55AM  BioSpecifics Technologies Reveals Positive Top-Line Results from Stage 2 Study Of CCH For Treatment of Human Lipoma
07:30AM  BioSpecifics Technologies Corp. Announces Positive Top-Line Results from Phase 2 Trial of CCH for Treatment of Human Lipoma PR Newswire
Jun-03-16 01:09PM  BIOSPECIFICS TECHNOLOGIES CORP Files SEC form 8-K, Submission of Matters to a Vote of Security Holders
Jun-02-16 07:30AM  BioSpecifics Technologies Corp. to Present at the Jefferies 2016 Healthcare Conference PR Newswire
May-31-16 03:04PM  BIOSPECIFICS TECHNOLOGIES CORP Files SEC form 8-K, Other Events, Financial Statements and Exhibits
07:30AM  BioSpecifics Technologies Corp. Announces Publication of Encouraging Data for Uterine Fibroid Treatment with CCH in American Journal of Obstetrics & Gynecology PR Newswire
May-27-16 05:03PM  BIOSPECIFICS TECHNOLOGIES CORP Files SEC form 8-K, Entry into a Material Definitive Agreement, Material Modification
May-26-16 07:23PM  ETFs with exposure to Biospecifics Technologies Corp. : May 26, 2016
May-23-16 02:08PM  Biospecifics Technologies Corp. :BSTC-US: Earnings Analysis: Q1, 2016 By the Numbers : May 23, 2016
May-18-16 09:18AM  BIOSPECIFICS TECHNOLOGIES CORP Files SEC form 8-K, Regulation FD Disclosure, Financial Statements and Exhibits
07:30AM  BioSpecifics Technologies Corp. to Present at the 2016 UBS Global Healthcare Conference PR Newswire
May-11-16 09:01AM  Repros (RPRX) Q1 Loss Narrower Y/Y, Pipeline in Focus Zacks -5.21%
May-10-16 07:47AM  BIOSPECIFICS TECHNOLOGIES CORP Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statement +6.99%
BioSpecifics Technologies Corp., a biopharmaceutical company, engages in the development of an injectable collagenase clostridium histolyticum for multiple indications in the United States. The company offers injectable collagenase for the treatment of Dupuytren's contracture and Peyronie's disease under the XIAFLEX brand in Canada and Australia, as well as under XIAPEX brand name in Europe. It also provides injectable collagenase to treat frozen shoulder, cellulite, canine lipoma, lateral hip fat, and plantar fibromatosis, as well as for the treatment of human lipoma and uterine fibroids. The company is also involved in the development of other clinical indications for which collagenase injection has been tested, such as keloids, hypertrophic scars, scarred tendons, glaucoma, herniated intervertebral discs, and as an adjunct to vitrectomy. It has a development and license agreement with Endo Global Ventures. BioSpecifics Technologies Corp. was founded in 1957 and is headquartered in Lynbrook, New York.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Wegman ThomasPresidentDec 08Sale49.5415,000743,112930,879Dec 13 10:39 AM
Wegman TobyDirectorNov 29Sale48.0810,000480,832949,973Nov 29 05:15 PM
Wegman ThomasPresidentNov 29Sale48.0810,000480,832949,973Nov 29 05:16 PM
Wegman ThomasPresidentNov 29Sale48.328,945432,188955,879Nov 29 05:15 PM
Wegman ThomasPresidentNov 28Sale48.0411,055531,048964,824Nov 29 05:15 PM
Wegman ThomasPresidentSep 15Sale41.213,100127,751959,973Sep 16 08:21 PM
Wegman TobyDirectorSep 15Sale41.213,100127,751959,973Sep 16 08:21 PM
Wegman TobyDirectorSep 13Sale37.553,605135,350963,073Sep 13 07:02 PM
Wegman ThomasPresidentSep 13Sale37.553,605135,350963,073Sep 13 07:01 PM
Wegman ThomasPresidentSep 02Sale37.501,26647,475966,678Sep 02 08:51 PM
Wegman TobyPresidentSep 02Sale37.501,26647,475966,678Sep 02 08:51 PM
Wegman TobyPresidentSep 01Sale37.537,935297,824967,944Sep 02 08:51 PM
Wegman ThomasPresidentSep 01Sale37.537,935297,824967,944Sep 02 08:51 PM
Wegman ThomasPresidentAug 30Option Exercise0.83125,000103,750312,549Aug 30 07:16 PM
Wegman ThomasPresidentAug 30Sale37.502,692100,957975,879Aug 30 07:16 PM
Wegman TobyPresidentAug 30Sale37.502,692100,957975,879Aug 30 07:17 PM
Wegman ThomasPresidentAug 29Sale37.611,60760,440978,571Aug 30 07:16 PM
Wegman TobyPresidentAug 29Sale37.611,60760,440978,571Aug 30 07:17 PM
Wegman ThomasPresidentAug 24Sale38.084,173158,897187,549Aug 24 07:40 PM
Wegman ThomasPresidentAug 23Sale38.604,100158,280191,722Aug 24 07:40 PM